Generic Drugs Market in Brazil (2007-2011)

Table of Contents

1. Analyst View

2. Global Generic Drugs Market

• 2.1 Market Size & Growth
• 2.2 Geographical Performance

3. Brazil Demographics & Healthcare Profile

• 3.1 Demographics & Macroeconomic Indicators
  • 3.1.1 Macroeconomic Indicators
  • 3.1.2 Population
  • 3.1.3 Life Expectancy
  • 3.1.4 Infant Mortality Rate
  • 3.1.5 Age Breakup
• 3.2 Healthcare Indicators
  • 3.2.1 Healthcare Structure
  • 3.2.2 Doctors & Hospital Beds
  • 3.2.3 Healthcare Expenditure
  • 3.2.4 Main Causes of Death

4. Brazil Pharmaceutical Market

• 4.1 Industry Performance
  • 4.1.1 Drug Categories
  • 4.1.2 Market Size & Growth
    • 4.1.2.1 Sales Value
    • 4.1.2.2 Sales Volume
  • 4.1.3 Private & Public Market
  • 4.1.4 Import & Export
  • 4.1.5 Major Pharmaceutical Segments
  • 4.1.6 Investments
  • 4.1.7 Performance of Key Players

5. Brazil Generic Drugs Market

• 5.1 Market Drivers
  • 5.1.1 Low Cost
  • 5.1.2 Strong Investment
  • 5.1.3 Strong Government Support
  • 5.1.4 Patent Expiries
  • 5.1.5 Ageing Population
  • 5.1.6 Strengthening of Real
  • 5.1.7 Increasing Prescription Rates
• 5.2 Industry Performance
  • 5.2.1 Market Size & Growth
    • 5.2.1.1 Sales Value
    • 5.2.1.2 Sales Volume
  • 5.2.2 Regulatory Environment
  • 5.2.3 Investments
  • 5.2.4 Performance of Key Players
• 5.3 Restraints
  • 5.3.1 Dependence on Imported Raw Materials
  • 5.3.2 Over-reliance of Domestic Generic Firms on Domestic Market
  • 5.3.3 Lack of Awareness & Low Prescriptions in Private Sector
  • 5.3.4 Prevalence of ' Similar Drugs'
  • 5.3.5 Counterfeit Drugs
• 5.4 Promising Segments in the Generic Business
  • 5.4.1 Antiretroviral
  • 5.4.2 Oral Contraceptives
  • 5.4.3 Erectile Dysfunction
  • 5.4.4 Anti-Thrombotics
  • 5.4.5 Cardiovascular Drugs
  • 5.4.6 Anti-diabetics

6. Future Outlook (2007-2011)

• 6.1 Pharmaceutical Market
• 6.2 Generic Drugs Market

7. Profiles of Key Players

• 7.1 EMS Sigma Pharma
• 7.2 Medley
• 7.3 Eurofarma Laboratorios Ltda
• 7.4 Aché Pharmaceutical Laboratories S/A
• 7.5 Ranbaxy

List of Figures:

• Figure 2-1: Global - Pharmaceutical Market (in Billion US$), 1999-2006
• Figure 2-2: Global - Generic Drugs Market (in Billion US$), 2001-2006
• Figure 2-3: Global - Revenues of Top 3 Generic Companies (in Billion US$), 2006
• Figure 2-4: Global - Forecast for Generic Drugs Market (in Billion US$), 2007-2011
• Figure 2-5: Global - Share of Generic Drugs in Pharmaceutical Market (%), 2006 & 2011F
• Figure 2-6: Global - Generic Drugs Market by Region (%), 2006
• Figure 2-7: Brazil & Global - Growth Rate of the Generic Drugs Market (%), 2006
• Figure 3-1: Brazil - Nominal GDP (in Trillion BRL) 2001-2006
• Figure 3-2: Brazil - Consumer Price Index (%), 2001-2006
• Figure 3-3: Brazil - Currency Exchange Rates (From US$ to BRL), 2001-2006
• Figure 3-4: Brazil - Foreign Direct Investment (in Billion US$), 2004-2006
• Figure 3-5: Brazil - Population (in Million), 2001-2006E
• Figure 3-6: Brazil - Life Expectancy of Male & Female (in Years), 2001-2006E
• Figure 3-7: Brazil - Infant Mortality Rate (per ‘000 Live Births), 2001-2006E
• Figure 3-8: Brazil - Population Breakup by Age (%), 2001-2006E
• Figure 3-9: Brazil - Number of Doctors (per ‘000 Population), 2001-2006E
• Figure 3-10: Brazil - Number of Hospital Beds (per ‘000 Population), 2002 & 2003E
• Figure 3-11: Brazil - Share of Healthcare Expenditure in GDP (%), 2001-2006E
• Figure 3-12: Brazil - Per Capita Healthcare Expenditure (in US$), 2001-2006E
• Figure 3-13: Brazil - Main Causes of Death (%), 2005E
• Figure 3-14: Brazil - Main Causes of Death (%), 2030F
• Figure 4-1: Brazil - Pharmaceutical Market Sales Value (in Billion BRL), 2001, 2002E & 2004-2006
• Figure 4-2: Brazil - Pharmaceutical Market Sales Value (in Billion US$), 2001, 2002E & 2004-2006
• Figure 4-3: Brazil - Pharmaceutical Market Sales Volume (in Billion Units), 2004-2006
• Figure 4-4: Brazil - Share of Public & Private Pharmaceutical Market (%), 2006
• Figure 4-5: Brazil - Private Pharmaceutical Market (in Billion BRL), 2004-2006
• Figure 4-6: Brazil - Public Pharmaceutical Market (in Billion BRL), 2004-2006
• Figure 4-7: Brazil - Pharmaceutical Exports Sales Value (in Million US$), 2004-2007F
• Figure 4-8: Brazil - Pharmaceutical Exports Sales Volume (in Tons) 2004-2007F
• Figure 4-9: Brazil - Pharmaceutical Imports Sales Value (in Billion US$), 2004-2007F
• Figure 4-10: Brazil - Pharmaceutical Imports Sales Volume (in Tons), 2004-2007F
• Figure 4-11: Brazil - Pharmaceutical Trade Deficit (in Million US$), 2004-2007F
• Figure 4-12: Brazil - Share of Major Segments of Pharmaceutical Market (%), 2006*
• Figure 4-13: Brazil - Pharmaceutical Investments (in Billion BRL), 2006 & 2007E
• Figure 4-14: Brazil - Share of Investment in Various Pharmaceutical Segments (%), 2007E
• Figure 5-1: Brazil - Price Comparison of Medley' s Generic Version of Plenty with its Branded Version (in BRL), 2006
• Figure 5-2: Brazil - Population above 65 Years (%), 2001-2006E
• Figure 5-3: Brazil - Share of Prescriptions for Branded & Generic Drugs in Pharmaceutical Market (%), 2005 & 2006
• Figure 5-4: Brazil - Share of Prescriptions for Atenolol, Cephalexin & Omeprazol in Branded & Generic Drugs Prescriptions (%), April 2006
• Figure 5-5: Brazil - Share (Sales Value) of Generic Drugs in Pharmaceutical Market (%), 2006
• Figure 5-6: Brazil - Generic Drugs Sales Value (in Million US$), 2004-2006
• Figure 5-7: Brazil - Growth Rate of Generic Drugs Sales Value (%), 2005 & 2006
• Figure 5-8: Brazil - Generic Drugs Sales Value (in Million US$), H1 2006 & H1 2007
• Figure 5-9: Brazil - Share (Sales Volume) of Generic Drugs in Pharmaceutical Market (%), 2006
• Figure 5-10: Brazil - Generic Drug Sales Volume (in Million Units), 2004-2006
• Figure 5-11: Brazil - Generic Drugs Sales Volume (in Million Units), H1 2006 & H1 2007
• Figure 5-12: Brazil - Investment in Generic Drugs (in Million US$), 2000-2006 & 2007-2011F
• Figure 5-13: Brazil - Breakup of Investment in Generic Drugs Market (%), 2007 to 2011
• Figure 5-14: Brazil - Number of Companies Manufacturing Generic Drugs (2000 & 2006)
• Figure 5-15: Brazil - Share of Top Players in Generic Drugs Market (%), 2006
• Figure 5-16: Brazil - Share of Imported & Locally Produced Raw Materials (%), 2006
• Figure 5-17: Brazil - Number of HIV Patients* & HIV Patients on Anti-Retroviral Therapy (in ‘000), 2006
• Figure 5-18: Brazil - Share of Top Players in Oral Contraceptives Market (%), 2006
• Figure 5-19: Brazil - Share of Top Players in Erectile Dysfunction Market (%), Nov 2006
• Figure 5-20: Brazil - Deaths from Cardiovascular Diseases (%), 2005 & 2030F
• Figure 5-21: Brazil - Cardiovasular Drugs Market (in Million US$), 2005 & 2006
• Figure 5-22: Brazil - Insulin Market (in Million US$), 2000, 2006 & 2010F
• Figure 6-1: Brazil - Forecast for Pharmaceutical Market (in Billion US$), 2007-2011
• Figure 6-2: Brazil - Forecast for Generic Drugs Market (in Billion US$), 2007-2011
• Figure 6-3: Brazil - Contribution of Generic & Non-Generics in Growth of Pharmaceutical Market (%), 2006-2011
• Figure 6-4: Brazil - Forecast for Share of Generic Drugs in Pharmaceutical Market (%), 2007-2011

List of Tables:

• Table 4-1: Brazil - Performance of Top 10 Players in Pharmaceutical Market, 2006
• Table 5-1: Brazil - Patent Expiry & Sales of Key Drugs
• Table 5-2: Brazil - Performance of Top Players in Generic Drugs Market (2005 & 2006)
• Table 5-3: Brazil - Erectile Dysfunction Market (in Million BRL), 2005 & 2006
• Table 5-4: Brazil - Diabetic Patients in Age Group 20-79 (in ' 000), 2003
• Table 5-5: Brazil - Forecast for Diabetic Patients in Age Group 20-79 (in ' 000), 2025